Author:
Somasagara R R,Spencer S M,Tripathi K,Clark D W,Mani C,Madeira da Silva L,Scalici J,Kothayer H,Westwell A D,Rocconi R P,Palle K
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference66 articles.
1. Foley OW, Rauh-Hain JA, del Carmen MG . Recurrent epithelial ovarian cancer: an update on treatment. Oncology 2013; 27: 288–294, 298.
2. Davis A, Tinker AV, Friedlander M . ‘Platinum resistant’ ovarian cancer: what is it, who to treat and how to measure benefit? Gynecol Oncol 2014; 133: 624–631.
3. Kandalaft LE, Powell DJ, Singh N, Coukos G . Immunotherapy for ovarian cancer: what’s next? J Clin Oncol 2011; 29: 925–933.
4. Abdullah LN, Chow EK-H . Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med 2013; 2: 3.
5. Khan IN, Al-Karim S, Bora RS, Chaudhary AG, Saini KS . Cancer stem cells: a challenging paradigm for designing targeted drug therapies. Drug Discov Today 2015; 20: 1205–1216.
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献